Polaramine and Pelvic abscess - a phase IV clinical study of FDA data

Summary:

Pelvic abscess is reported only by a few people who take Polaramine.

The phase IV clinical study analyzes which people take Polaramine and have Pelvic abscess. It is created by eHealthMe based on reports of 9,238 people who have side effects while taking Polaramine from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 19, 2023

9,238 people reported to have side effects when taking Polaramine.
Among them, 5 people (0.05%) have Pelvic abscess.

What is Polaramine?

Polaramine has active ingredients of dexchlorpheniramine maleate. It is often used in allergic rhinitis. eHealthMe is studying from 9,289 Polaramine users for its effectiveness, alternative drugs and more.

What is Pelvic abscess?

Pelvic abscess is found to be associated with 603 drugs and 263 conditions by eHealthMe.

Number of Polaramine and Pelvic abscess reports submitted per year:

Time on Polaramine when people have Pelvic abscess *:

Gender of people who have Pelvic abscess when taking Polaramine *:

female: 0.0 %
male: 100 %

Age of people who have Pelvic abscess when taking Polaramine *:

Common drugs people take besides Polaramine *:

Sodium Bicarbonate: 4 people, 80.00%
Fluorouracil: 3 people, 60.00%
Erbitux: 3 people, 60.00%
Dexamethasone Sodium Phosphate: 3 people, 60.00%
Tysabri: 1 person, 20.00%
Solu-Medrol: 1 person, 20.00%
Neulasta: 1 person, 20.00%
Cabazitaxel: 1 person, 20.00%

Common side effects people have besides Pelvic abscess *:

Groin Abscess (pus in groin): 4 people, 80.00%
Dermatitis Acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis): 3 people, 60.00%
Skin Reaction: 1 person, 20.00%
Liver Disorder (liver diseases): 1 person, 20.00%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 1 person, 20.00%
Aortic Aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall): 1 person, 20.00%

Common conditions people have *:

Colon Cancer: 4 people, 80.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 20.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Polaramine and have Pelvic abscess?

Check whether Pelvic abscess is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Pelvic abscess and when was it recovered:

Pelvic abscess in Polaramine

Expand to all the drugs that have ingredients of dexchlorpheniramine maleate:

Pelvic abscess and drugs with ingredients of dexchlorpheniramine maleate

Alternative drugs to, pros and cons of Polaramine:

Polaramine (9,289 reports)

Common Polaramine side effects:

Browse all side effects of Polaramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pelvic abscess treatments and more:

Pelvic abscess (1,539 reports)

COVID vaccines that are related to Pelvic abscess:

Common drugs associated with Pelvic abscess:

Prednisone: 141 reports
Accutane: 129 reports
Humira: 123 reports

All the drugs that are associated with Pelvic abscess:

Pelvic abscess (603 drugs)

Common conditions associated with Pelvic abscess:

Crohn's disease: 311 reports

All the conditions that are associated with Pelvic abscess:

Pelvic abscess (263 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dexchlorpheniramine maleate (the active ingredients of Polaramine) and Polaramine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.